LTFS
MYGN icon

Ladenburg Thalmann Financial Services’s Myriad Genetics MYGN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$38K Sell
1,403
-6
-0.4% -$165 ﹤0.01% 3706
2019
Q3 		$41K Sell
1,409
-294
-17% -$8.57K ﹤0.01% 3576
2019
Q2 		$47K Sell
1,703
-233
-12% -$6.58K ﹤0.01% 3510
2019
Q1 		$64K Sell
1,936
-515
-21% -$15.7K ﹤0.01% 3232
2018
Q4 		$70K Buy
2,451
+702
+40% +$25.3K ﹤0.01% 3015
2018
Q3 		$81K Sell
1,749
-482
-22% -$21.4K ﹤0.01% 2970
2018
Q2 		$65K Hold
2,231
– – ﹤0.01% 3075
2018
Q1 		$65K Sell
2,231
-592
-21% -$20K ﹤0.01% 3075
2017
Q4 		$97K Sell
2,823
-53
-2% -$1.79K ﹤0.01% 2750
2017
Q3 		$104K Buy
2,876
+222
+8% +$6.33K ﹤0.01% 2577
2017
Q2 		$68K Buy
2,654
+210
+9% +$4.46K ﹤0.01% 2790
2017
Q1 		$47K Buy
2,444
+10
+0.4% +$177 ﹤0.01% 2963
2016
Q4 		$41K Buy
2,434
+592
+32% +$10.7K ﹤0.01% 2986
2016
Q3 		$38K Buy
1,842
+430
+30% +$10.9K ﹤0.01% 2999
2016
Q2 		$43K Buy
1,412
+91
+7% +$3.16K ﹤0.01% 2797
2016
Q1 		$49K Sell
1,321
-196
-13% -$7.38K ﹤0.01% 2612
2015
Q4 		$65K Buy
1,517
+179
+13% +$7.56K ﹤0.01% 2380
2015
Q3 		$50K Sell
1,338
-195
-13% -$6.92K ﹤0.01% 2474
2015
Q2 		$52K Sell
1,533
-430
-22% -$14.6K ﹤0.01% 2558
2015
Q1 		$69K Sell
1,963
-43
-2% -$1.54K ﹤0.01% 2331
2014
Q4 		$68K Sell
2,006
-63
-3% -$2.23K ﹤0.01% 2157
2014
Q3 		$80K Sell
2,069
-226
-10% -$8.43K ﹤0.01% 1732
2014
Q2 		$89K Buy
2,295
+157
+7% +$5.84K ﹤0.01% 1680
2014
Q1 		$73K Sell
2,138
-42,394
-95% -$1.31M ﹤0.01% 1698
2013
Q4 		$934K Buy
44,532
+42,522
+2,116% +$1.08M 0.03% 466
2013
Q3 		$47K Buy
2,010
+115
+6% +$3.27K ﹤0.01% 1866
2013
Q2 		$51K Buy
+1,895
New +$54.9K ﹤0.01% 1725

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MYGN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Myriad Genetics (MYGN) stake by 0.43% in Q4 2019, selling an estimated $165 and leaving 1,403 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #3706.

Ladenburg Thalmann Financial Services first reported a position in MYGN in Q2 2013 and has held it in 27 quarters since. The position peaked at $934K in Q4 2013. 227 funds tracked by Wall St. Rank hold MYGN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,403 shares of Myriad Genetics worth $38K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 6 Myriad Genetics shares in Q4 2019, an estimated $165.
  • Myriad Genetics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3706 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Myriad Genetics in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Myriad Genetics position peaked at $934K in Q4 2013.
  • 227 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.